A detailed history of Whipplewood Advisors, LLC transactions in Natera, Inc. stock. As of the latest transaction made, Whipplewood Advisors, LLC holds 753 shares of NTRA stock, worth $111,782. This represents 0.06% of its overall portfolio holdings.

Number of Shares
753
Previous 941 19.98%
Holding current value
$111,782
Previous $149 Million 27.85%
% of portfolio
0.06%
Previous 0.08%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 09, 2025

SELL
$132.63 - $177.0 $24,934 - $33,276
-188 Reduced 19.98%
753 $107 Million
Q4 2024

Feb 04, 2025

BUY
$117.67 - $174.0 $110,727 - $163,734
941 New
941 $149 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $14.4B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Whipplewood Advisors, LLC Portfolio

Follow Whipplewood Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Whipplewood Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Whipplewood Advisors, LLC with notifications on news.